The global market for Peri-Implantitis was estimated at US$1.1 Billion in 2024 and is projected to reach US$1.6 Billion by 2030, growing at a CAGR of 6.4% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Peri-Implantitis market.
Unlike peri-implant mucositis, which is confined to soft tissue inflammation, peri-implantitis involves irreversible bone damage. This condition can result in pain, implant mobility, and even loss of the implant. As implant procedures rise globally in both restorative and cosmetic dentistry, awareness and clinical management of peri-implantitis are becoming critical to maintaining long-term success rates.
Treatment options include mechanical debridement, antiseptic irrigation, systemic or local antibiotics, and surgical intervention such as guided bone regeneration or implant surface decontamination. Emerging therapies include laser-assisted debridement, photodynamic therapy, and biologic agents to promote bone healing. Implant design and surface coatings are being modified to reduce biofilm adhesion and enhance tissue integration, thus lowering risk of recurrence.
Dental device manufacturers, biomaterials developers, and oral hygiene product companies are investing in innovations to address peri-implantitis. Academic research is also expanding into regenerative therapies and biofilm control strategies. Integration of digital health records and regular implant maintenance programs is helping dental professionals monitor implant health more closely and reduce the burden of late-stage peri-implant disease.
Technological improvements in surgical techniques, implant surface modification, and non-invasive therapies are broadening clinical options for intervention. Regulatory emphasis on implant safety and post-market surveillance is also promoting investment in peri-implantitis prevention and management tools. With the aging population and growing use of implant-supported prosthetics, peri-implantitis management is becoming a vital segment within periodontal and restorative dentistry.
Segments: Type (Non-Surgical Type, Surgical Type); End-Use (Dental Clinics End-Use, Hospitals End-Use)
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Global Peri-Implantitis Market - Key Trends & Drivers Summarized
What Is Peri-Implantitis and Why Is It Emerging as a Dental Health Concern?
Peri-implantitis is a progressive inflammatory condition affecting soft and hard tissues around dental implants, leading to bone loss and potential implant failure. It typically develops from poor plaque control, mechanical overload, or systemic health factors such as diabetes or smoking. As dental implants become more widespread, peri-implantitis is being increasingly recognized as a significant complication requiring timely diagnosis and intervention.Unlike peri-implant mucositis, which is confined to soft tissue inflammation, peri-implantitis involves irreversible bone damage. This condition can result in pain, implant mobility, and even loss of the implant. As implant procedures rise globally in both restorative and cosmetic dentistry, awareness and clinical management of peri-implantitis are becoming critical to maintaining long-term success rates.
How Are Diagnosis and Treatment Modalities Evolving in Clinical Practice?
Diagnosis is based on clinical assessment of inflammation, bleeding on probing, increased pocket depth, and radiographic bone loss. Advances in diagnostic tools, including digital imaging, 3D cone-beam computed tomography, and peri-implant tissue biomarkers, are enabling earlier and more accurate detection. Standardized diagnostic protocols are also being developed to differentiate peri-implantitis from other inflammatory conditions.Treatment options include mechanical debridement, antiseptic irrigation, systemic or local antibiotics, and surgical intervention such as guided bone regeneration or implant surface decontamination. Emerging therapies include laser-assisted debridement, photodynamic therapy, and biologic agents to promote bone healing. Implant design and surface coatings are being modified to reduce biofilm adhesion and enhance tissue integration, thus lowering risk of recurrence.
Where Is Clinical Demand Increasing and Which Stakeholders Are Focusing on Solutions?
Dental clinics, periodontists, and implantology centers are the primary settings for managing peri-implantitis. Demand is rising in both developed and emerging markets due to greater use of implants in aging populations, aesthetic dentistry, and full-arch rehabilitation. Patients with risk factors such as poor oral hygiene, history of periodontitis, or smoking are more likely to develop complications, prompting clinicians to adopt preventive and early-intervention strategies.Dental device manufacturers, biomaterials developers, and oral hygiene product companies are investing in innovations to address peri-implantitis. Academic research is also expanding into regenerative therapies and biofilm control strategies. Integration of digital health records and regular implant maintenance programs is helping dental professionals monitor implant health more closely and reduce the burden of late-stage peri-implant disease.
Growth in the Peri-Implantitis market is driven by several factors
Growth in the peri-implantitis market is driven by factors such as rising global prevalence of dental implants, increased recognition of implant-related complications, and evolving standards in oral healthcare. Demand for advanced diagnostics, effective treatment protocols, and implant maintenance solutions is increasing among dental professionals seeking to preserve implant longevity.Technological improvements in surgical techniques, implant surface modification, and non-invasive therapies are broadening clinical options for intervention. Regulatory emphasis on implant safety and post-market surveillance is also promoting investment in peri-implantitis prevention and management tools. With the aging population and growing use of implant-supported prosthetics, peri-implantitis management is becoming a vital segment within periodontal and restorative dentistry.
Scope Of Study:
The report analyzes the Peri-Implantitis market in terms of units by the following Segments, and Geographic Regions/Countries:Segments: Type (Non-Surgical Type, Surgical Type); End-Use (Dental Clinics End-Use, Hospitals End-Use)
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Non-Surgical Type segment, which is expected to reach US$866.0 Million by 2030 with a CAGR of a 5.0%. The Surgical Type segment is also set to grow at 8.3% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $292.3 Million in 2024, and China, forecasted to grow at an impressive 9.8% CAGR to reach $315.7 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Peri-Implantitis Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Peri-Implantitis Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Peri-Implantitis Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as 3M, Alpha-Bio Tec, BioHorizons, Biomatlante, CAMLOG Biotechnologies and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 36 companies featured in this Peri-Implantitis market report include:
- 3M
- Alpha-Bio Tec
- BioHorizons
- Biomatlante
- CAMLOG Biotechnologies
- DENTSPLY SIRONA
- Geistlich Pharma
- Hiossen Implant
- Institut Straumann AG
- Keystone Dental
- Medentika
- MegaGen Implant
- MIS Implants Technologies
- Neobiotech
- Nobel Biocare
- Osstem Implant
- PARADENT Dental
- Southern Implants
- Thommen Medical
- ZimVie
This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:
- Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
- Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
- Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
- Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
- Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
- Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
- Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3M
- Alpha-Bio Tec
- BioHorizons
- Biomatlante
- CAMLOG Biotechnologies
- DENTSPLY SIRONA
- Geistlich Pharma
- Hiossen Implant
- Institut Straumann AG
- Keystone Dental
- Medentika
- MegaGen Implant
- MIS Implants Technologies
- Neobiotech
- Nobel Biocare
- Osstem Implant
- PARADENT Dental
- Southern Implants
- Thommen Medical
- ZimVie
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 267 |
Published | July 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value in 2024 | 1.1 Billion |
Forecasted Market Value by 2030 | 1.6 Billion |
Compound Annual Growth Rate | 6.4% |
Regions Covered | Global |